Drug Database
Back to search

Norway· NO-ID_AF0341C9-451B-46B5-B342-F2953AC25EDE

Xeljanz

A tofacitinib product containing tofacitinib, registered in Norway by Pfizer Europe MA EEIG (1). The same ATC class is registered in 13 of our 19 countries.

ATC L04AF01

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedXeljanzATCL04AF01REGISTER NO.NO-ID_AF0341C9-451B-4…PACKS LISTED3CHECKEDSeptember 25, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about tofacitinibAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Tofacitinib is registered in 13 of 19 countries.

Countries holding a registration under ATC L04AF01 (tofacitinib), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 7 of them publish a price we can compare per daily dose
Search tofacitinib products by name

Tofacitinib · ATC L04AF01

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of tofacitinib costs, country by country.

Normalised to the WHO defined daily dose (10 mg), the median price runs from $1.99 in United States to $17.31 in Switzerland — a ×8.7 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail
Open the full comparison — free accountDrug prices for market access

Tofacitinib · price per daily dose (10 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$17.31
  • US United States$1.99 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

FEST (Norway)
Active substance
Tofacitinib
Manufacturer
Pfizer Europe MA EEIG (1)
Country
Norway (NO)
ATC code
L04AF01
ATC class
Tofacitinib
Defined daily dose
10 mg, O
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
September 25, 2026

Packs & prices · 3

1 priced
  • no_varenummer
    094146
    28
    NOK 8965.1
  • no_merkevare_id
    ID_AF0341C9-451B-46B5-B342-F2953AC25EDE
  • gtin
    5415062344507

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

512 interactions on record for tofacitinib.

Graded by severity as the source publishes them — 333 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check tofacitinib against other medicinesHow interaction checks work

Tofacitinib · interactions on record

512 records

  • 333 severe
  • 171 moderate
  • 8 minor

Most severe, free to view

  • PrednisoloneA07EA01severe
  • HydrocortisoneA07EA02severe
  • PrednisoneA07EA03severe
  • BetamethasoneA07EA04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Tofacitinib in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tofacitinib products

Authorised across Europe · EMA

The same active substance is authorised in 14 EEA countries. Names it is sold under:

  • Austria · Tofacitinib Devatis, Tofacitinib Stada
  • Bulgaria · Tофацитиниб Devatis
  • Denmark · Tofacitinib Accord, Tofacitinib Newbury
  • Spain · Tofacitinib Stada
  • Finland · Tofacitinib Devatis, Tofacitinib Stada
  • France · Tofacitinib Stada
  • United Kingdom (Northern Ireland) · Tofacitinib Amarox, Tofacitinib Brown & Burk Uk
  • Croatia · Tofacitinib Accord, Tofacitinib Stada
  • Iceland · Xeljanz
  • Liechtenstein · Xeljanz
  • Malta · Tofacitinib Stada
  • Netherlands · Tofacitinib Devatis, Tofacitinib Stada
  • Portugal · Tofacitinib Bluepharma
  • Sweden · Tofacitinib Devatis, Tofacitinib Newbury

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/9e477bc6-3b11-4d3b-8502-b8bdcebb0ca5
GET /v1/drugs/9e477bc6-3b11-4d3b-8502-b8bdcebb0ca5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Depottablett",
  "source": "fest",
  "status": "A",
  "atc_name": "Tofacitinib",
  "merkevare_id": "ID_AF0341C9-451B-46B5-B342-F2953AC25EDE",
  "name_form_strength": "Xeljanz depottab 11 mg",
  "prescription_group": "C"
}
API referenceMCP serverPlans

See everything about tofacitinib.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console